Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on Oct 17, 2019 5:38pm
69 Views
Post# 30241849

RE:RE:RE:The market

RE:RE:RE:The market
BioTeck wrote: In all seriousness, most of the people here are here for the share price. Of course it'd be great for those who suffer from the disease as well. Given the history of the stock, I agree that short of a release that says sernova cures diabetes, the price will continue to bounce between 20 and 30 cents. For people like me, that's great. For people who are long, not so much. The biggest problem is that you are taking significant risk but are getting rewarded very little. The lack of details in the releases would be of concern if I was long. The fact that only 4 people are enrolled is also troubling. Each day that is wasted is a day closer to a general pullback in overall markets or a day lost in the edge sernova had/has over the competition. Also, don't forget about the shares that become free trading in the next month. If something doesn't change, the price will struggle at 20 cents as investors in the private placement unload their shares and keep the free warrant as insurance. I hope that mgmt gets their act together and enters into some kind of deal because short of that, I think your money is better invested elsewhere. Don't be fooled, this is still an extremely high risk play regardless of what the sentiment on this board is.



Bioteck,

You are by the far the largest pessimestic negative pesrson against Sernova. Firstly, pp shares dont trade until December.  There are alot of investors that are long and are not here for the sp on a daily basis.  Why are you here is this is a high risk investment?  Just flipping for pennies. You are an antagonist that pretends otherwise. I do agree that management has handled this badly and time is a factor. On the other technology is showing promise. So keep subtly fear mongering, at the end, it wont make a difference.  Most investors do not make decisions by reading bullboards.
Bullboard Posts